Organ-on-a-chip technology and microfluidic whole-body models for pharmacokinetic drug toxicity screening
The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Microscale cell culture platforms better mimic the in vivo cellular microenvironment than conventional, macroscale systems. Microscale cultures therefore elicit a more authentic response from cultured cells, enabling physiologically realistic in vitro tissue models to be constructed. The fabrication of interconnecting microchambers and microchannels allows drug absorption, distribution, metabolism and elimination to be simulated, and enables precise manipulation of fluid flow to replicate blood circulation. Complex, multi‐organ interactions can be investigated using “organ‐on‐a‐chip” toxicology screens. By reproducing the dynamics of multi‐organ interaction, the dynamics of various diseases and drug activities can be studied in mechanistic detail. In this review, we summarize the current status of technologies related to pharmacokinetic‐based drug toxicity testing, and the use of microtechnology for reproducing the interaction between multiple organs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The origins and the future of microfluidics
Whitesides, G. M. (2006) · Nature · doi:10.1038/nature05058 · Cited by 9,687 · cited 2×
“Microfluidics, which deals with very small quantities of liquids (nanoliters to microliters) using channels with dimensions of micrometers, has been largely applied to chemical synthesis and analytical chemistry [6].”
BackgroundMethodReconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250 · cited 3×
“One prominent example from the Ingber group [18] describes a lung-on-a-chip platform able to respond to bacterial and inflammatory cytokines introduced into alveolar space and replicate drug-induced pulmonary edema [41].”
BackgroundAbbott, A. (2003) · Nature · doi:10.1038/424870a · Cited by 1,234 · cited 1×
“These interactions often exist in three-dimensional (3D) context [3]; (ii) The cellular microenvironment found in vivo is often heterogeneous.”
BackgroundMicroscale culture of human liver cells for drug development
Khetani, S. R., & Bhatia, S. N. (2008) · Nature Biotechnology · doi:10.1038/nbt1361 · Cited by 1,219 · cited 3×
“[35] developed a liver-on-a-chip, in which the microscale architecture of the human liver tissue was reproduced by co-culturing hepatocytes and fibroblasts in precisely defined areas.”
BackgroundPDMS absorption of small molecules and consequences in microfluidic applications
Toepke, M. W., & Beebe, D. J. (2006) · Lab on a Chip · doi:10.1039/b612140c · Cited by 1,190 · cited 5×
“J. 2013, 8 6 © 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Ithis work, liver slices were sandwiched between PDMS layers and perfused with media.”
BackgroundInfluentialA Human Disease Model of Drug Toxicity–Induced Pulmonary Edema in a Lung-on-a-Chip Microdevice
Huh, D., Leslie, D. C., Matthews, B. D., Fraser, J. P., Jurek, S., Hamilton, G. A., Thorneloe, K. S., McAlexander, M. A., & Ingber, D. E. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004249 · Cited by 993 · cited 2×
“One prominent example from the Ingber group [18] describes a lung-on-a-chip platform able to respond to bacterial and inflammatory cytokines introduced into alveolar space and replicate drug-induced pulmonary edema [41].”
BackgroundEngineering of functional, perfusable 3D microvascular networks on a chip
Kim, S., Lee, H., Chung, M., & Jeon, N. L. (2013) · Lab on a Chip · doi:10.1039/c3lc41320a · Cited by 872 · cited 1×
“During the last few years, several organ-on-a-chip systems have been developed, including blood vessel [32, 33], liver [34, 35], gastrointestinal tract [19, 36, 37], blood-brain-barrier [38, 39], lung [18, 40, 41], kidney [42, 43], and heart [21, 44, 45] equivalents.”
BackgroundHuman kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment
Jang, K.-J., Mehr, A. P., Hamilton, G. A., McPartlin, L. A., Chung, S., Suh, K.-Y., & Ingber, D. E. (2013) · Integrative Biology · doi:10.1039/c3ib40049b · Cited by 849 · cited 1×
“During the last few years, several organ-on-a-chip systems have been developed, including blood vessel [32, 33], liver [34, 35], gastrointestinal tract [19, 36, 37], blood-brain-barrier [38, 39], lung [18, 40, 41], kidney [42, 43], and heart [21, 44, 45] equivalents.”
BackgroundMicroengineered hydrogels for tissue engineering
Khademhosseini, A., & Langer, R. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.07.021 · Cited by 830 · cited 1×
“Therefore, recent research efforts have been directed towards fabricating hydrogels into 3D shapes mimicking the geometry of the target organs [25].”
BackgroundDesign of pressure-driven microfluidic networks using electric circuit analogy
Oh, K. W., Lee, K., Ahn, B., & Furlani, E. P. (2012) · Lab Chip · doi:10.1039/c2lc20799k · Cited by 685 · cited 1×
“The analogy between electrical circuits and microfluidic devices not only applies to a single channel, but it can also be extended to a more complex network of microchannels [30].”
BackgroundMicroengineered physiological biomimicry: Organs-on-Chips
Huh, D., Torisawa, Y.-S., Hamilton, G. A., Kim, H. J., & Ingber, D. E. (2012) · Lab on a Chip · doi:10.1039/c2lc40089h · Cited by 667 · cited 1×
“More detailed coverage of recent developments in various organ-on-a-chip devices is out of scope of this paper, but is summarized in several recently published review articles [7, 8, 47].”
BackgroundCell Mechanics: Integrating Cell Responses to Mechanical Stimuli
Janmey, P. A., & McCulloch, C. A. (2007) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.9.060906.151927 · Cited by 630 · cited 1×
“For example, the adherence of cells on surface via integrin binding is responsible not only for physical attachment, but also the transduction of signals affecting the cell motility, shape and cell cycle [23].”
BackgroundMicrofluidic scaffolds for tissue engineering
Choi, N. W., Cabodi, M., Held, B., Gleghorn, J. P., Bonassar, L. J., & Stroock, A. D. (2007) · Nature Materials · doi:10.1038/nmat2022 · Cited by 622
Biomolecular gradients in cell culture systems
Keenan, T. M., & Folch, A. (2008) · Lab Chip · doi:10.1039/b711887b · Cited by 596
Ensembles of engineered cardiac tissues for physiological and pharmacological study: Heart on a chip
Grosberg, A., Alford, P. W., McCain, M. L., & Parker, K. K. (2011) · Lab on a Chip · doi:10.1039/c1lc20557a · Cited by 544 · cited 1×
“During the last few years, several organ-on-a-chip systems have been developed, including blood vessel [32, 33], liver [34, 35], gastrointestinal tract [19, 36, 37], blood-brain-barrier [38, 39], lung [18, 40, 41], kidney [42, 43], and heart [21, 44, 45] equivalents.”
BackgroundGriep, L. M., Wolbers, F., de Wagenaar, B., ter Braak, P. M., Weksler, B. B., Romero, I. A., Couraud, P. O., Vermes, I., van der Meer, A. D., & van den Berg, A. (2013) · Biomedical Microdevices · doi:10.1007/s10544-012-9699-7 · Cited by 537 · cited 1×
“During the last few years, several organ-on-a-chip systems have been developed, including blood vessel [32, 33], liver [34, 35], gastrointestinal tract [19, 36, 37], blood-brain-barrier [38, 39], lung [18, 40, 41], kidney [42, 43], and heart [21, 44, 45] equivalents.”
BackgroundA microfluidic device for a pharmacokinetic–pharmacodynamic (PK–PD) model on a chip
Sung, J. H., Kam, C., & Shuler, M. L. (2010) · Lab on a Chip · doi:10.1039/b917763a · Cited by 484 · cited 1×
“Later, the μCCA was modified further to allow easier insertion of 3D hydrogel cell culture [55].”
MethodSelf-citationSung, J. H., & Shuler, M. L. (2009) · Lab on a Chip · doi:10.1039/b901377f · Cited by 431 · cited 2×
“The most straightforward scheme is to match the residence times for each organ [54].”
BackgroundMethodSelf-citationIn Vitro Perfused Human Capillary Networks
Moya, M. L., Hsu, Y.-H., Lee, A. P., Hughes, C. C. W., & George, S. C. (2013) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2012.0430 · Cited by 387 · cited 1×
“During the last few years, several organ-on-a-chip systems have been developed, including blood vessel [32, 33], liver [34, 35], gastrointestinal tract [19, 36, 37], blood-brain-barrier [38, 39], lung [18, 40, 41], kidney [42, 43], and heart [21, 44, 45] equivalents.”
BackgroundSin, A., Chin, K. C., Jamil, M. F., Kostov, Y., Rao, G., & Shuler, M. L. (2008) · Biotechnology Progress · doi:10.1021/bp034077d · Cited by 368
Biomimetic tissues on a chip for drug discovery
Ghaemmaghami, A. M., Hancock, M. J., Harrington, H., Kaji, H., & Khademhosseini, A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.10.029 · Cited by 359
Zhang, C., Zhao, Z., Abdul Rahim, N. A., van Noort, D., & Yu, H. (2009) · Lab on a Chip · doi:10.1039/b915147h · Cited by 340 · cited 1×
“[56], was designed for culturing multiple 3D cell aggregates to mimic multiple organs.”
BackgroundSyM-BBB: a microfluidic blood brain barrier model
Prabhakarpandian, B., Shen, M.-C., Nichols, J. B., Mills, I. R., Sidoryk-Wegrzynowicz, M., Aschner, M., & Pant, K. (2013) · Lab on a Chip · doi:10.1039/c2lc41208j · Cited by 339 · cited 1×
“During the last few years, several organ-on-a-chip systems have been developed, including blood vessel [32, 33], liver [34, 35], gastrointestinal tract [19, 36, 37], blood-brain-barrier [38, 39], lung [18, 40, 41], kidney [42, 43], and heart [21, 44, 45] equivalents.”
BackgroundMicroscale 3-D hydrogel scaffold for biomimetic gastrointestinal (GI) tract model
Sung, J. H., Yu, J., Luo, D., Shuler, M. L., & March, J. C. (2011) · Lab Chip · doi:10.1039/c0lc00273a · Cited by 320 · cited 2×
“During the last few years, several organ-on-a-chip systems have been developed, including blood vessel [32, 33], liver [34, 35], gastrointestinal tract [19, 36, 37], blood-brain-barrier [38, 39], lung [18, 40, 41], kidney [42, 43], and heart [21, 44, 45] equivalents.”
BackgroundMethodSelf-citationThree-dimensional cellular microarray for high-throughput toxicology assays
Lee, M.-Y., Kumar, R. A., Sukumaran, S. M., Hogg, M. G., Clark, D. S., & Dordick, J. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708756105 · Cited by 314 · cited 2×
“Metabolites were formed by the reaction of a drug with P450 enzyme, which were subsequently incubated with target cells to test cytotoxicity [48].”
MethodSivaraman, A., Leach, J., Townsend, S., Iida, T., Hogan, B., Stolz, D., Fry, R., Samson, L., Tannenbaum, S., & Griffith, L. (2005) · Current Drug Metabolism · doi:10.2174/138920005774832632 · Cited by 310
Development of a Microscale Cell Culture Analog To Probe Naphthalene Toxicity
Viravaidya, K., Sin, A., & Shuler, M. L. (2008) · Biotechnology Progress · doi:10.1021/bp0341996 · Cited by 305
Sung, J. H., Esch, M. B., Prot, J.-M., Long, C. J., Smith, A., Hickman, J. J., & Shuler, M. L. (2013) · Lab on a Chip · doi:10.1039/c3lc41017j · Cited by 233 · cited 1×
“More detailed coverage of recent developments in various organ-on-a-chip devices is out of scope of this paper, but is summarized in several recently published review articles [7, 8, 47].”
BackgroundSelf-citationIn Vitro Zonation and Toxicity in a Hepatocyte Bioreactor
Allen, J. W. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi052 · Cited by 233 · cited 1×
“During the last few years, several organ-on-a-chip systems have been developed, including blood vessel [32, 33], liver [34, 35], gastrointestinal tract [19, 36, 37], blood-brain-barrier [38, 39], lung [18, 40, 41], kidney [42, 43], and heart [21, 44, 45] equivalents.”
BackgroundMahler, G. J., Esch, M. B., Glahn, R. P., & Shuler, M. L. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22366 · Cited by 221 · cited 2×
“A microfluidic device mimicking the gastrointestinal (GI) tract was developed to simulate the drug absorption process [37].”
BackgroundMethodMacro- and microscale fluid flow systems for endothelial cell biology
Young, E. W. K., & Simmons, C. A. (2010) · Lab Chip · doi:10.1039/b913390a · Cited by 215 · cited 1×
“For example, a gradient of biomolecular concentrations or substrate stiffness often exists in human tissue; however, conventional cell culturebased screening systems are usually constructed on homogeneous substrates [4]; (iii) The presence of blood flow provides a dynamic environment and mechanical stimuli, while most…”
BackgroundPersistent hepatitis C virus infection in microscale primary human hepatocyte cultures
Ploss, A., Khetani, S. R., Jones, C. T., Syder, A. J., Trehan, K., Gaysinskaya, V. A., Mu, K., Ritola, K., Rice, C. M., & Bhatia, S. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915130107 · Cited by 211 · cited 1×
“In a subsequent study, they demonstrated that the co-culture system can support the life cycle of hepatitis C virus: the co-cultured hepatocyte cells expressed known hepatitis C viral entry factors and sustained viral replication for several weeks [46].”
Backgroundvan Midwoud, P. M., Merema, M. T., Verpoorte, E., & Groothuis, G. M. M. (2010) · Lab on a Chip · doi:10.1039/c0lc00043d · Cited by 203
Organs-on-a-Chip: A Focus on Compartmentalized Microdevices
Moraes, C., Mehta, G., Lesher-Perez, S. C., & Takayama, S. (2012) · Annals of Biomedical Engineering · doi:10.1007/s10439-011-0455-6 · Cited by 199 · cited 1×
“More detailed coverage of recent developments in various organ-on-a-chip devices is out of scope of this paper, but is summarized in several recently published review articles [7, 8, 47].”
BackgroundPBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals
Bois, F. Y., Jamei, M., & Clewell, H. J. (2010) · Toxicology · doi:10.1016/j.tox.2010.06.007 · Cited by 194 · cited 1×
“The conventional least-square method can be used, and more sophisticated methods such as the Bayesian technique have also been employed [12].”
MethodFlow rate analysis of a surface tension driven passive micropump
Berthier, E., & Beebe, D. J. (2007) · Lab on a Chip · doi:10.1039/b707637a · Cited by 191 · cited 1×
“While pressure-driven flow is still a dominant mode, passive methods such as gravity-induced flow have also been used [28, 29].”
MethodEarly prediction of drug metabolism and toxicity: systems biology approach and modeling
Bugrim, A., Nikolskaya, T., & Nikolsky, Y. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02971-4 · Cited by 188 · cited 1×
“Pharmacokinetic and pharmacodynamics profiles remain difficult to predict, contributing to the high attrition rate of candidate drugs during the development process [1].”
BackgroundPMMA/PDMS valves and pumps for disposable microfluidics
Zhang, W., Lin, S., Wang, C., Hu, J., Li, C., Zhuang, Z., Zhou, Y., Mathies, R. A., & Yang, C. J. (2009) · Lab on a Chip · doi:10.1039/b907254c · Cited by 183 · cited 1×
“Using this principle, pneumatic microvalves and micropumps have been developed [27].”
MethodChen, M. B., Srigunapalan, S., Wheeler, A. R., & Simmons, C. A. (2013) · Lab on a Chip · doi:10.1039/c3lc00051f · Cited by 179 · cited 1×
“During the last few years, several organ-on-a-chip systems have been developed, including blood vessel [32, 33], liver [34, 35], gastrointestinal tract [19, 36, 37], blood-brain-barrier [38, 39], lung [18, 40, 41], kidney [42, 43], and heart [21, 44, 45] equivalents.”
BackgroundJang, K.-J., Cho, H. S., Kang, D. H., Bae, W. G., Kwon, T.-H., & Suh, K.-Y. (2011) · Integr. Biol. · doi:10.1039/c0ib00018c · Cited by 177
Engineering Challenges for Instrumenting and Controlling Integrated Organ-on-Chip Systems
Wikswo, J. P., Block, F. E., Cliffel, D. E., Goodwin, C. R., Marasco, C. C., Markov, D. A., McLean, D. L., McLean, J. A., McKenzie, J. R., Reiserer, R. S., et al. (2013) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2013.2244891 · Cited by 176 · cited 1×
“[59], due to the miniaturization over many orders of magnitude, it is not a straightforward task to construct a microscale device that correctly matches the volume, mass and flow rate ratios between different organs.”
BackgroundJusko, W. J. (1971) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600600618 · Cited by 160 · cited 1×
“For example, many chemotherapeutic agents result in irreversible cell death, which is often only observed after significant time has elapsed since administration [14].”
BackgroundPharmacokinetic/Pharmacodynamic Studies in Drug Product Development
Meibohm, B., & Derendorf, H. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1167 · Cited by 159 · cited 1×
“The details of integrated PK-PD model are beyond the scope of this article and are reviewed elsewhere [15, 16].”
MethodIn vitro 3D human small intestinal villous model for drug permeability determination
Yu, J., Peng, S., Luo, D., & March, J. C. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24518 · Cited by 158 · cited 1×
“For example, hydrogel microstructures mimicking the intestinal villi structure have been fabricated and used for drug absorption studies [19, 26].”
MethodSung, J. H., & Shuler, M. L. (2009) · Biomedical Microdevices · doi:10.1007/s10544-009-9286-8 · Cited by 148 · cited 1×
“(v) The fifth challenge is an engineering issue related to the operation of devices, such as molecular absorption to PDMS [64], controlling mass transport inside the device [65], and preventing air bubble formation inside the device [66].”
BackgroundSelf-citationAgoram, B. M., Martin, S. W., & van der Graaf, P. H. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.002 · Cited by 146 · cited 1×
“Pharmacokinetic-pharmacodynamic (PK-PD) modeling is a mathematical modeling technique that is aimed at predicting the tissue concentration profile (PK) and the final pharmacological effect (PD) of drugs [2].”
Backgroundvan Midwoud, P. M., Groothuis, G. M. M., Merema, M. T., & Verpoorte, E. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.22516 · Cited by 135 · cited 1×
“[50] developed a microfluidic device for the perfusion culture of precision-cut tissue slices.”
BackgroundPaclitaxel pharmacokinetics and pharmacodynamics.
Kearns, C. M., Gianni, L., & Egorin, M. J. (1995) · PubMed · Cited by 126
Co-culture of epithelial cells and bacteria for investigating host–pathogen interactions
Kim, J., Hegde, M., & Jayaraman, A. (2010) · Lab Chip · doi:10.1039/b911367c · Cited by 120 · cited 2×
“Several approaches have been taken, such as connecting each compartment with tubing [58], integrating all chambers on a single chip [52], or using pneumatic valves to control flow between compartments [36].”
BackgroundMethodLi, A. P., Bode, C., & Sakai, Y. (2004) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2004.09.010 · Cited by 112 · cited 1×
“Another interesting example is the integrated discrete multiple organ cell culture (IDMOC) system developed by Li et al [49], which is based on the concept of “wells within a well” to culture multiple cell types inside a single well.”
BackgroundPhysiologically based pharmacokinetic modelling: a sound mechanistic basis is needed
Aarons, L. J. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02560.x · Cited by 110 · cited 1×
“KGaA, Weinheim 3 tion of those processes [10].”
BackgroundAnalysis of oxygen transport in a diffusion‐limited model of engineered heart tissue
Brown, D. A., MacLellan, W. R., Laks, H., C.Y. Dunn, J., M. Wu, B., & Beygui, R. E. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21295 · Cited by 102 · cited 1×
“However, without vascularization, such a method often results in limitations in mass transport of nutrients and oxygen [24].”
BackgroundMicrofluidic Cardiac Cell Culture Model (μCCCM)
Giridharan, G. A., Nguyen, M.-D., Estrada, R., Parichehreh, V., Hamid, T., Ismahil, M. A., Prabhu, S. D., & Sethu, P. (2010) · Analytical Chemistry · doi:10.1021/ac1012893 · Cited by 92 · cited 1×
“During the last few years, several organ-on-a-chip systems have been developed, including blood vessel [32, 33], liver [34, 35], gastrointestinal tract [19, 36, 37], blood-brain-barrier [38, 39], lung [18, 40, 41], kidney [42, 43], and heart [21, 44, 45] equivalents.”
BackgroundIn vitro microscale systems for systematic drug toxicity study
Sung, J. H., & Shuler, M. L. (2009) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-009-0369-y · Cited by 82 · cited 1×
“Mimicking the cellular microenvironment of the natural tissues is thought to elicit more authentic responses from cultured cells than the cells cultured in conventional, macroscale culture environment [22].”
BackgroundSelf-citationIntegrated??Pharmacokinetics??and Pharmacodynamics in??Drug??Development
Dingemanse, J., & Appel‐Dingemanse, S. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746090-00001 · Cited by 75 · cited 1×
“The details of integrated PK-PD model are beyond the scope of this article and are reviewed elsewhere [15, 16].”
MethodMicrotechnology for Mimicking In Vivo Tissue Environment
Sung, J. H., & Shuler, M. L. (2012) · Annals of Biomedical Engineering · doi:10.1007/s10439-011-0491-2 · Cited by 70 · cited 1×
“The future direction of ‘organ-on-a-chip’ research is likely to be directed towards connecting those authentic functionalities to mimic a whole-body response [67, 68].”
BackgroundSelf-citationDeveloping a tissue-engineered model of the human bronchiole
Miller, C., George, S., & Niklason, L. (2010) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.277 · Cited by 67 · cited 1×
“During the last few years, several organ-on-a-chip systems have been developed, including blood vessel [32, 33], liver [34, 35], gastrointestinal tract [19, 36, 37], blood-brain-barrier [38, 39], lung [18, 40, 41], kidney [42, 43], and heart [21, 44, 45] equivalents.”
BackgroundA mini-microscope for in situ monitoring of cells
Kim, S. B., Koo, K.-I., Bae, H., Dokmeci, M. R., Hamilton, G. A., Bahinski, A., Kim, S. M., Ingber, D. E., & Khademhosseini, A. (2012) · Lab on a Chip · doi:10.1039/c2lc40345e · Cited by 64 · cited 1×
“In fact, several research groups have developed custom in situ detection systems to analyze metabolites [60], cell viability [61, 62], and cell migration [63].”
BackgroundIntegration of in silico and in vitro platforms for pharmacokinetic–pharmacodynamic modeling
Sung, J. H., Esch, M. B., & Shuler, M. L. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2010.496251 · Cited by 64 · cited 1×
“The future direction of ‘organ-on-a-chip’ research is likely to be directed towards connecting those authentic functionalities to mimic a whole-body response [67, 68].”
BackgroundSelf-citationMorier, P., Vollet, C., Michel, P., Reymond, F., & Rossier, J. S. (2004) · Electrophoresis · doi:10.1002/elps.200406093 · Cited by 54 · cited 1×
“While pressure-driven flow is still a dominant mode, passive methods such as gravity-induced flow have also been used [28, 29].”
MethodVozzi, F., Heinrich, J.-M., Bader, A., & Ahluwalia, A. D. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2008.0066 · Cited by 53 · cited 2×
“Alternatively a more complicated approach such as allometric scaling technique can be employed [57, 58].”
BackgroundMethodSung, J. H., Choi, J., Kim, D., & Shuler, M. L. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22413 · Cited by 45
Self-citationGuzzardi, M. A., Domenici, C., & Ahluwalia, A. (2011) · Tissue Engineering Part A · doi:10.1089/ten.tea.2010.0541 · Cited by 30 · cited 4×
“Several approaches have been taken, such as connecting each compartment with tubing [58], integrating all chambers on a single chip [52], or using pneumatic valves to control flow between compartments [36].”
BackgroundMethodInfluentialReal‐time fluorescence detection of multiple microscale cell culture analog devices in situ
Oh, T., Sung, J. H., Tatosian, D. A., Shuler, M. L., & Kim, D. (2007) · Cytometry Part A · doi:10.1002/cyto.a.20427 · Cited by 27 · cited 1×
“In fact, several research groups have developed custom in situ detection systems to analyze metabolites [60], cell viability [61, 62], and cell migration [63].”
BackgroundSelf-citationInvestigation into modification of mass transfer kinetics by acrolein in a renal biochip
Ramello, C., Paullier, P., Ould‐Dris, A., Monge, M., Legallais, C., & Leclerc, É. (2011) · Toxicology in Vitro · doi:10.1016/j.tiv.2011.03.017 · Cited by 21
Choi, J., Sung, J. H., Shuler, M. L., & Kim, D. (2010) · Optics Letters · doi:10.1364/ol.35.001374 · Cited by 20 · cited 1×
“In fact, several research groups have developed custom in situ detection systems to analyze metabolites [60], cell viability [61, 62], and cell migration [63].”
BackgroundSelf-citationSegui, A., Lebaron, J. P., & Leverge, R. (1986) · IEE Proceedings D Control Theory and Applications · doi:10.1049/ip-d.1986.0036 · Cited by 15
Interfacial properties of barium sulfate suspensions. Implications in their stability.
Gallardo, V., Zurita, L., Ontiveros, A., & Durán, J. D. G. (2000) · Journal of Pharmacy and Science · doi:10.1002/1520-6017(200009)89:9<1212::aid-jps13>3.0.co;2-4 · Cited by 11
Cited by
Organs-on-chips at the frontiers of drug discovery
Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185
Three-Dimensional Cell Cultures in Drug Discovery and Development
Fang, Y., & Eglen, R. M. (2017) · SLAS Discovery · doi:10.1177/1087057117696795 · Cited by 849
“Integrating multiple organ types into one chip, termed as body-on-a-chip, can be powerful for comprehending the pharmacokinetics and pharmacodynamics of drug molecules.(119,120) However, developing screeningcompatible body-on-a-chip remains a challenging task, in particular when one considers the known allometric scal…”
BackgroundA liver-on-a-chip platform with bioprinted hepatic spheroids
Bhise, N. S., Manoharan, V., Massa, S., Tamayol, A., Ghaderi, M., Miscuglio, M., Lang, Q., Shrike Zhang, Y., Shin, S. R., Calzone, G., et al. (2016) · Biofabrication · doi:10.1088/1758-5090/8/1/014101 · Cited by 615
Lee, H., & Cho, D.-W. (2016) · Lab on a Chip · doi:10.1039/c6lc00450d · Cited by 363
Organ-on-a chip systems: microengineering to biomimic living systems
Zheng, F., Fu, F., Cheng, Y., Wang, C., Zhao, Y., & Gu, Z. (2016) · Small · doi:10.1002/smll.201503208 · Cited by 338
Metadata
- Authors
- Lee, J. B., & Sung, J. H.
- Affiliations
- University of Seoul (KR)
- Hongik University (KR)
- Venue
- Biotechnology Journal
- Publisher
- Wiley
- Published
- 2013-08-23
- Volume
- 8
- Issue
- 11
- Pages
- 1258-1266
- ISSN
- 1860-6768 (ISSN-L)
- 1860-7314
- OpenAlex
- W2015699419
- Cited by
- 92
- References
- 68
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 4 · 2023: 6 · 2022: 5 · 2021: 8 · 2020: 4 · 2019: 9 · 2018: 11 · 2017: 16 · 2016: 6 · 2015: 7 · 2014: 4 · 2013: 2
- FWCI
- 0.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biotechnology Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- organ-on-a-chip, in vitro toxicology
- MeSH terms
- Cells, Cultured, Drug Evaluation, Preclinical, Humans, Models, Biological, Pharmacokinetics, Microfluidics, Cellular Microenvironment, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.